Browse > Article

Relationship of serum IL-13 and eotaxin level with airway hyperresponsiveness in children with asthma  

Park, Eun Young (Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine)
Shim, Jung Yeon (Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine)
Yoo, Myung Hwan (Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine)
Kim, Deok Soo (Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine)
Shim, Jae Won (Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine)
Jung, Hye Lim (Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine)
Park, Moon Soo (Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine)
Publication Information
Clinical and Experimental Pediatrics / v.49, no.8, 2006 , pp. 889-894 More about this Journal
Abstract
Purpose : Asthma is characterized by the presence of airway hyperresponsiveness(AHR) and inflammation. The extensive eosinophil infiltration into the lung is the hallmark of asthma and contributes to the damage of respiratory epithelium during late phase airway responses. Eotaxin is the major eosinophil chemoattractant found in bronchoalveolar lavage(BAL) fluid of allergic inflammation. IL-13 has been known to induce the expression of exotaxin and eosinophilia. IL-13 also induces airway inflammation, mucus production and leads to marked fibrosis, airway remodeling and AHR. We investigated whether serum IL-13 levels can reflect the presence of airway hyperresponsiveness in children with asthma, and the relationship between serum IL-13 and eotaxin levels. Methods : Using sandwich enzyme-linked immunosorbent assay, the serum IL-13 and eotaxin levels were measured in 13 atopic asthmatics, 5 atopic non-asthmatics and 12 control subjects. Metacholine challenge tests were performed in all subjects. Airway hyperresponsiveness to metacholine was expressed as provocative concentration of metacholine causing a 20% fall in FEV1[$PC_{20}mg/mL$]. $PC_{20}$ value of 25 mg/mL was used as a cut-off for defining a AHR. Results : Serum IL-13 levels showed positive correlation with eotaxin levels. Serum IL-13 and eotaxin levels showed no differences among atopic asthmatics, atopic non-asthmatics and control subjects. And there were no differences serum IL-13 and eotaxin levels in children with and without AHR and atopy. Serum IL-13 and eotaxin levels did not correlate with $logPC_{20}$ levels. Conclusion : IL-13 is closely related to the eotaxin release. But serum IL-13 and eotaxin per se can't predict the severity of airway hyperresponsiveness. IL-13 and eotaxin may have local effect on respiratory epithelium or there can be some factors to induce airway hyperresponsiveness other than serum IL-13 in asthmatic airways.
Keywords
Asthma; Airway hyperresponsiveness; Interleukin-13; Eotaxin;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, et al. Inter leukin-13 : Central mediator of allergic asthma. Science 1998;282:2258-61   DOI   ScienceOn
2 Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J, et al. Pulmonary expression of interleukin-13 causes inflmmation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clincal Invest 1999;103:779-89   DOI   ScienceOn
3 Yang M, Hogan SP, Mahalingam S, Pope SM, Zimmermann N, Fulkerson P, et al. Eotaxin-2 and IL-5 cooperate in the lung to regulate IL-13 production and airway eosinophilia and hyperreactivity. J Allergy Clin Immunol 2003; 112:935-43   DOI   ScienceOn
4 Li L, Xia Y, Nguyen A, Lai YH, Feng L, Mosmann TR, et al. Effect of Th2 cytokines on chemokine expression in the lung : IL-13 potently induces eotaxin expression by airway epithelial cells. J Immunol 1999;162:2477-87
5 Pope SM, Brandt EB, Mishra A, Hogan SP, Zimmermann N, Matthaei KI, et al. IL-13 induces eosinophil recruitment into the lung by an IL-5 and eotaxin dependent mechanism. J Allergy Clin Immunol 2001;108:594-601   DOI   ScienceOn
6 Schmid-Grendelmeier P, Altznauer F, Fischer B, Bizer C, Straumann A, Menz G, et al. Eosinophils express functional IL-13, in eosinophilic inflammatory disease. J Immunol 2002;169:1021-7   DOI
7 Min JW, Jang AS, Park SM, Lee JH, Park SW, Park CS. Comparison of plasma eotaxin family level in aspirininduced and aspirin-tolerant asthma patient. Chest 2005;128: 127-32
8 Li J, Saito H, Crawford L, Inman MD, Cyr MM, Denburg JA. Haemopoietic mechanisms in murine allergic upper and lower airway inflammation. Immunology 2005;114:386-96   DOI   ScienceOn
9 Venkayya R, Lam M, Willkom M, Grunig G, Corry DB, Erle DJ. The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyperresponsiveness through direct effects on resident airway cells. Am J Respir Cell Mol Biol 2002;26:202-8   DOI   ScienceOn
10 Chang JY, Shin SA, Oh JW, Lee HB. Crucial factors for bronchial hyperresponsiveness in children with mild asthma. Pediatr Allergy Respir Dis 2005;15:142-9
11 Moore PE, Church TL, Chism DD, Panettieri RA Jr, Shore SA. IL-13 and IL-4 cause eotaxin release in human airway smooth muscle cells : a role for ERK. Am J Physiol Lung Cell Mol Physiol 2002;282:847-52   DOI
12 Yang G, Volk A, Petley T, Emmell E, Giles-Komar J, Shang X, et al. Anti-IL-13 monoclonal antibody inhibits airway hyperresponsiveness, inflammation and airway remodeling. Cytokine 2004;28:224-32   DOI   ScienceOn
13 O'Bryan L, Pinkston P, Kumaraswami V, Vijayan V, Yenokida G, Rosenberg HF, et al. Localized eosinophil degranulation mediates disease in tropical pulmonary eosinophilia. Infect Immun 2003;71:1337-42   DOI
14 Shin SA, Oh JW, Lee HB, Kim NS, Lee HB. Relationship between airway hyperresposiveness and duration of asthma in children. J Asthma Allergy Clin Immunol 2003;23:77-83
15 Matsukura S, Stellato C, Georas SN, Casolaro V, Plitt JR, Miura K, et al. Interleukin-13 upregulates eotaxin expression in airway epithelial cells by a STAT6-dependent mechanism. Am J Respir Cell Mol Biol 2001;24:755-61   DOI   ScienceOn
16 Taube C, Duez C, Cui ZH, Takeda K, Rha YH, Park JW, et al. The role of IL-13 in established allergic airway disease. J Immunol 2002;169:6482-9   DOI
17 Hummelshoj T, Bodtger U, Datta P, Malling HJ, Oturai A, Poulsen K, et al. Association between an interleukin-13 promotor polymorphism and atopy. Eur J Immunogenet 2003;30:355-9   DOI   ScienceOn
18 Walter DM, McIntire JJ, Berry G, McKenzie AN, Donaldson DD, DeKruyff RH, et al. Critical role for IL-13 in the development of allergen-induced airway hyperreactivity. J Immunol 2001;167:4668-75   DOI
19 Jung EM, Kim HS, Kang IJ. A 10 year follow-up childhood asthma : Potential risk factors on persistence of nonspecific bronchial hyperresponsiveness. Pediatr Allergy Respir Dis 2002;12:82-92
20 Zhou G, Zhai Y, Dong X, Zhang X, He F, Zhou K, et al. Haplotype structure and evidence for positive selection at the human IL13 locus. Mol Biol Evol 2004;21:29-35
21 Kim JT. Evaluation of inflammation in childhood asthma; Non-invasive measurement. J Korean Pediatr Soc 2001;44: 334-9
22 Zimmermann N, Hershey GK, Foster PS, Rothenberg ME. Chemokines in asthma : Cooperative interaction between chemokines and IL-13. J Allergy Clin Immunol 2003;111: 227-42   DOI   ScienceOn
23 The Korean Academy of Pediatric Allergy and Respiratory Disease. The guideline for diagnosis and management of childhood asthma. 2nd ed. Seoul : Sowha Co, 1999:5-87
24 Chai H, Farr RS, Froehlich LA, Mathison DA, McLean JA, Rosenthal RR, et al. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 1975;56:323- 58   DOI
25 Arima K, Umeshita-Suyama R, Sakata Y, Akaiwa M, Mao XQ, Enomoto T, et al. Upregulation of IL-13 concentraion in vivo the IL-13 variant associated with bronchial asthma. J Allergy Clin Immunol 2002;109:980-7   DOI   ScienceOn